Cargando…
Off-Label Uses of Rituximab in Dermatology
PURPOSE OF REVIEW: Rituximab has transformed the treatment of B-cell malignancies and rheumatoid arthritis in the past 2 decades. More recently, this anti-CD20 monoclonal antibody has seen increasing usage in the field of dermatology. This review highlights the evidence supporting its use in several...
Autores principales: | Cole, Connor, Amber, Kyle T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534735/ https://www.ncbi.nlm.nih.gov/pubmed/36217351 http://dx.doi.org/10.1007/s13671-022-00375-4 |
Ejemplares similares
-
Climate Change and Inpatient Dermatology
por: Fathy, R., et al.
Publicado: (2020) -
Inpatient Dermatology Best Practice Strategies for Educating and Relaying Findings to Colleagues
por: Faletsky, Adam, et al.
Publicado: (2020) -
Neutrophilic Dermatoses: a Clinical Update
por: Weiss, Emma H., et al.
Publicado: (2022) -
Neutrophilic Dermatosis and Management Strategies for the Inpatient Dermatologist
por: Shah, Nishi, et al.
Publicado: (2022) -
SARS-CoV-2 Infection and Vaccination Cutaneous Manifestations for the Inpatient Dermatologist
por: Himed, Sonia, et al.
Publicado: (2022)